# Trade Mark Journal No.2025/047 21 November 2025

## WO0000001885050 (5)

Office of origin: United States of America

Date of International Registration:10 October 2025
Date of designation in the UK: 10 October 2025

International priority date claimed: 7 October 2025 (United States of America) (99431691)

Class 5
  Pharmaceutical preparations targeting the HER2 protein for the treatment of cancer; immunotherapy preparations targeting the HER2 protein for the treatment of cancer; vaccine preparations targeting the HER2 protein for the treatment of cancer.

OS Therapies Inc.

Representative: Neha Bhalani Chiesa Shahinian & Giantomasi PC, 105 Eisenhower Parkway, Roseland NJ 07068, UNITED STATES OF AMERICA